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Few studies have researched the gender‑specific effects of electronic nicotine delivery systems on 
the metabolic syndrome (MetS) and/or its risk factors (central obesity, raised triglycerides, decreased 
HDL cholesterol, raised blood pressure, raised fasting plasma glucose). Thus, this study investigated 
the association between smoking behavior (cigarette type, smoking history) and MetS in a nationally 
representative sample of Korean men and women. Our study employed data for 5,462 cases of MetS 
and 12,194 controls from the Korea National Health and Nutritional Examination Survey (KNHANES) 
for the years 2014 to 2017. Logistic regression analysis was employed to determine the association 
between type of cigarette (non‑smoker, ex‑smoker, and current smoker—conventional only, current 
smoker—conventional and electronic) and the prevalence of metabolic syndrome and its risk factors. 
Smoking history was clinically quantified by pack‑year. No association between cigarette type and 
MetS was found for men. For women, relative to non‑smokers, smokers of conventional cigarettes (OR 
1.80, 95% CI 1.02–3.18) and both conventional and electronic cigarettes (OR 4.02, 95% CI 1.48–10.93) 
had increased odds of MetS. While there was no association between smoking history and MetS 
for women, for men, conventional smoking history was associated with MetS for individuals with a 
smoking history of > 25 pack‑years (> 25 to ≤ 37.5 OR 1.45, 95% CI 1.04–2.02; > 37.5 to ≤ 50 OR 1.53, 
95% CI 1.08–2.18; > 50 OR 1.56, 95% CI 1.07–2.27). Sex differences were found in the association 
between smoking behavior and MetS. Such findings reveal sociodemographic differences that should 
be considered for interventions regarding conventional and/or e‑cigarette users at risk of metabolic 
complications.
The metabolic syndrome (MetS) and its risk factors (central obesity, raised triglycerides, decreased HDL cho-
lesterol, raised blood pressure, raised fasting plasma glucose) have been vital in helping identify individuals at 
risk of type 2 diabetes and cardiovascular disease (CVD). Although a catalyst for heart disease, lipid problems, 
hypertension, dementia, cancer, polycystic ovarian syndrome, and non-alcoholic fatty liver  disease1, the mecha-
nisms underlying the development of MetS remain obscure. What is certain is that a growing body of literature 
asserts that various lifestyle factors including smoking, alcohol  consumption2, diet, and physical  activity3 con-
tribute to its onset.
Electronic nicotine delivery systems, also known as e-cigarettes, are battery-powered products that deliver 
nicotine in the form of an  aerosol4. Currently, the ever use of e-cigarettes is 8.5% in the United States and 6.6% 
in South  Korea5. Often advertised as a “healthier” alternatives to conventional cigarettes or smoking cessation 
aids, e-cigarettes purportedly do not involve tobacco combustion and therefore, have reduced toxicant exposure 
compared to traditional  cigarettes6.
However, research on long-term toxicity has been limited and studies attempting to show the efficacy of 
e-cigarettes as a healthier alternative to conventional smoking have had mixed  results6. In particularly, while 
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many studies have found a positive association between conventional cigarette smoking and the metabolic 
 syndrome7–11, few have examined the effects of e-cigarettes, on MetS and/or its risk factors.
The existing body of literature on the effects of e-cigarettes on lipid profile is both limited and inconsistent. 
In one study, e-cigarettes were associated with weight loss and a decrease in some participants’ blood sugar and 
cholesterol  levels12. In another study, users of e-cigarettes who completely quit regular cigarette smoking were 
less likely to report weight gain when compared with continuing smokers and  reducers13. In a study comparing 
Wistar rats administered and not administered with e-liquid with nicotine exposure, a significant decrease in 
cholesterol and LDL levels were found in the e-cigarette  group14. In a recent study comparing e-cigarette smokers 
to non-smokers, e-cigarette use was found to be associated with systemic oxidative stress, which is an indirect 
catalyst of cardiovascular  risk15.
Conversely, in another study of mice exposed to e-cigarettes, it was shown that when exposed to equivalent 
doses of nicotine as conventional cigarettes, the weight reducing effects of nicotine were not  found16. In another 
study of the effects of e-cigarettes on heart rate and blood pressure, it was found that e-cigarettes have no effect 
on blood pressure or pulse among daily  users17 although it should be noted that Konstatinos Farsalinos has a 
long history of funding from e-cigarette companies.
Thus, scholars have emphasized that the metabolic effects of e-cigarettes should be further evaluated, espe-
cially with direct comparisons of the health effects of e-cigarettes with those of conventional  cigarettes18. In the 
present study, we examined the association between electronic cigarette and/or conventional cigarette usage and 
MetS. This association was also stratified for the following risk factors of MetS: central obesity, raised triglycer-
ides, decreased HDL cholesterol, raised blood pressure, raised fasting plasma glucose.
Materials and methods
Study population and data. This study was conducted using data from the Korea National Health and 
Nutrition Examination Survey (KNHANES). The KNHANES aims to evaluate the health and nutritional status 
of South Koreans and provide data for the development and evaluation of health policies and programs in Korea. 
The survey produces statistics regarding smoking, drinking, physical activity, and obesity for the  WHO19 and the 
Organization for Economic Cooperation and Development (OECD).
The KNHANES is conducted by the Korean Ministry of Health and Welfare in conjunction with the Centers 
for Disease Control and Prevention (CDC). Survey data is obtained by specially trained interviewers who are 
not provided with any prior information about participants. Surveys are performed throughout 192 regions each 
year and 10,000 individuals ≥ 1 year of age are targeted.
For the purpose of our study, we examined the data of 17,656 individuals who participated in the survey 
between the years of 2014 and 2017. 1,738 individuals diagnosed by a medical professional with type 1 or type 2 
diabetes were excluded from our study, as well as subjects with missing information about cigarette type, smok-
ing history (pack-year), and/or the risk factors of MetS.
Measures. Outcome variable. In this study, the prevalence of the metabolic syndrome and its components 
was selected as the outcome variable. The presence of MetS was measured using the International Diabetes Fed-
eration’s definition specific to South  Asians2. According to the IDF’s worldwide definition, those with MetS are 
required to be centrally obese (measured by a waist circumference of ≥ 90 cm if male and ≥ 80 cm if female), as 
well as have two of the following four features: (1) an increased triglyceride level of ≥ 150 mg/dL or specific treat-
ment; (2) a decreased high density lipoprotein cholesterol level of < 40 mg/dL in men and < 50 mg/dL in women 
or specific treatment; (3) raised blood pressure, indicated by a systolic blood pressure of ≥ 130 mmHg, a diastolic 
blood pressure of ≥ 85 mmHg, or treatment of previously diagnosed hypertension; and (4) an increased fasting 
plasma glucose level of ≥ 100 mg/dL or previously diagnosed type 2 diabetes. Such components, as well as all 
health-related components of the KNHANES, were collected via standardized physical examination by medical 
technicians serving as staff members for the  survey2.
Cigarette type. The survey asked all subjects whether they used cigarettes or e-cigarettes currently or had 
ever used these products during their lifetime. Accordingly, we classified the subjects into four categories: non-
smoker, ex-smoker, current smoker (conventional only), and current smoker (conventional and electronic). This 
classification was in accordance with that of previous studies investigating cigarette type with the same survey 
 instrument20.
Covariates. Demographic, socioeconomic, and health-related covariates were included in this study. Covar-
iates included age (20–29, 30–39, 40–49, 50–59, 60–69, ≥ 70), smoking history (≤ 5, > 5 to ≤ 10, > 10 to ≤ 15, > 15 
to ≤ 20, > 20 to ≤ 25, > 25 to ≤ 37,0.5, > 37.5 to ≤ 50, > 50)21, level of physical activity (low, high), region (urban, 
rural), high-risk drinking (no, yes), menopause (no, yes- natural, yes-sartificial)22, serum hs-CRP levels (low: 
less than or equal to 3.0 mg/L, high: above 3.0 mg/L)23, household income group (low, medium–low, medium–
high, high), occupation (white collar, sales and services, blue collar), and educational attainment (≤ elementary 
school, middle school, high school diploma, ≥ bachelor’s degree) and year of survey (2014, 2015, 2016, 2017). 
The International Physical Activity Questionnaire was adopted to determine the level of physical activity. “High” 
physical activity was defined as ≥ 20 min of vigorous-intensity physical activity for ≥ 3 days a week, or ≥ 30 min 
of light- or moderate-intensity physical activity ≥ 5  days a  week24. Income groups were obtained by dividing 
household income by the square root of the number of members in a household, which is the standard method 
recommended by the Organization for Economic Cooperation and Development (OECD)25.
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Statistical analysis. To examine the association between cigarette type and MetS, as well as its risk factors, 
multivariate logistic regression analysis was performed using weighted data, while controlling for all demo-
graphic, socioeconomic, and health-related covariates. Odds ratios and 95% confidence  intervals26 were cal-
culated to compare non-smokers with ex-smokers, current smokers (conventional only), and current smokers 
(conventional and electronic). The calculated p-values in this study were considered significant if lower than 
0.05. All analyses were performed using SAS software, version 9.4 (SAS Institute, Cary, North Carolina, USA).
Results
Table 1 presents the general characteristics of our study population. 5,462 cases of MetS and 12,194 controls 
were analyzed from the Korea National Health and Nutritional Examination Survey (KNHANES) for the years 
2014 to 2017. Among cases of MetS, 45.9% were males and 54.1% were females. Among controls, 37.6% were 
males and 62.4% were females.
Table 2 presents the factors associated with MetS, found through the results of our logistic regression analysis. 
While there was no association between cigarette type and MetS for men, for women, relative to non-smokers, 
smokers of conventional cigarettes (OR 1.80, 95% CI 1.02–3.18) and both conventional and electronic cigarettes 
(OR 4.02, 95% CI 1.48–10.93) had increased odds of MetS. While there was no association between smoking 
history and MetS for women, for men, conventional smoking history was associated with MetS for individuals 
with a smoking history of > 25 pack-years (> 25 to ≤ 37.5 OR 1.45, 95% CI 1.04–2.02; > 37.5 to ≤ 50 OR 1.53, 95% 
CI 1.08–2.18; > 50 OR 1.56, 95% CI 1.07–2.27). A high level of physical activity was associated with decreased 
odds of MetS for both males (OR 0.88, 95% CI 0.80–0.98) and females (OR 0.85, 95% CI 0.78–0.94) compared 
to low, while high-risk drinking was associated with increased odds of MetS for both males (OR 1.89, 95% CI 
1.67–2.14) and females (OR 1.52, 95% CI 1.21–1.91). Females with artificial menopause also had increased odds 
of MetS (OR 1.54, 95% CI 1.54–1.23–1.92). A serum hs-CRP level greater than 3.0 mg/L was associated with 
increased odds of MetS for both males (OR 1.51, 95% CI 1.26–1.80) and females (OR 2.45, 95% CI 2.01–2.98).
Figures 1 and 2 show the association between cigarette usage and the odds of MetS and its components for 
both males and females. For females, the combined usage of both conventional and electronic cigarettes was 
associated with increased odds of high triglycerides (OR 3.90, 95% CI 1.54–9.89) and high fasting plasma glucose 
(OR 2.73, 95% CI 1.02–7.31).
Discussion
We found that the prevalence of MetS was significantly associated with cigarette type for females only. We also 
found that for females, cigarette type was associated with some of the components of MetS (high triglycerides, 
high fasting plasma glucose levels). This was in alignment with some previous studies which show that type of 
both conventional and electronic cigarettes is higher in toxicity than single type of the conventional cigarette 
 only27,28. Interestingly, raised blood pressure was not associated with electronic cigarette type although previ-
ous studies have noted that electronic cigarette smoking increases aortic stiffness and blood pressure in young 
smokers (age: 30 ± 8 years)29.
What is undeniable is that cigarette smoking is associated with increased total cholesterol, low-density lipo-
protein, while decreasing the cardio-protective high-density  lipoprotein18. Smoking cessation has also been 
associated with decreased odds of MetS after a certain period of  time18. While our study shows no clear associa-
tion between MetS and cigarette type with regard to the type of smoke used (conventional vs. conventional and 
electronic), the conventional smoking history variable continuously shows that a pack year of 20 or above is 
consistently associated with increased odds of MetS, central obesity, high triglycerides, low HDL cholesterol, high 
blood pressure, and high fasting plasma glucose among males. Our findings show that while cigarette type may be 
relevant for female users, for male users, the number and duration of cigarettes smoked may be more important.
Regarding sexual differences, previous studies have acknowledged that smoking is more strongly associated 
with insulin resistance and increased cardiovascular risk among women than  men28. More research is neces-
sary to determine how cigarette type and/or type may be more hazardous, than smoking history for women, as 
opposed to men. This study has several limitations that must be taken into consideration. Firstly, cigarette type, 
as well as variables related to smoking history and health-related behaviors were measured and classified based 
on self-reports, meaning that there may be various recall and information biases. A more accurate analysis would 
be possible if health-related behaviors could be measured through medical tests e.g. a urinary cotinine test for 
tobacco use. Likewise, in the KNHANES, individuals were not asked about e-cigarette use in the past, and so 
exclusive ex-smokers of e-cigarettes could not be separated from conventional ex-smokers in our main analysis, 
nor could the history or duration of e-cigarette smoking be adjusted for in pack-years.
Our study population was limited to adults, however, many studies have highlighted the popularity of e-ciga-
rette and dual e-cigarette and tobacco use among middle and high school adolescents which future studies should 
take into  account28, 30. Also, complete causal inferences are impossible to determine because the study design is 
cross-sectional and does not allow for lifetime trajectories of smoking, smoking cessation, and/or the develop-
ment of MetS over time. Studies have shown that the risk of metabolic syndrome can persist up to 20 years after 
the cessation of  smoking31. Thus, it is impossible to know if the use of e-cigarettes, and/or conventional cigarettes 
is responsible for the onset of MetS or its risk factors.
Likewise, some valuable but unknown or immeasurable confounders may have been excluded from our 
analysis because of the study design. Factors such as lifetime smoking trajectories, and/or the use of medications 
like statin were immeasurable from our data but likely had an effect on the association between cigarette type 
and MetS. Furthermore, because of the cross-sectional nature of our data, reverse causality bias is a concern; 
individuals with unhealthy profiles for MetS components may have been induced to stop smoking or not use 
e-cigarettes. This must be taken into account when interpreting our results. Lastly, other parameters that have 
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Total
Cases (n = 5,462)
p-value Total
Controls (n = 12,194)
p-value
Male Female Male Female
N % N % N % N %
Cigarette type
Non-smoker 3,193 499 (15.6) 2,694 (84.4)
< 0.0001
8,182 1,321 (16.1) 6,861 (83.9)
< 0.0001
Ex-smoker 1,293 1,154 (89.2) 139 (10.8) 2,420 1,941 (80.2) 479 (19.8)
Current smoker (conventional only) 893 781 (87.5) 112 (12.5) 1,432 1,189 (83.0) 243 (17.0)
Current smoker (conventional and electronic) 83 74 (89.2) 9 (10.8) 160 134 (83.8) 26 (16.3)
Smoking history (pack-years)
Non-smoker 3,284 563 (17.1) 2,721 (82.9)
< 0.0001
8,466 1,492 (17.6) 6,974 (82.4)
< 0.0001
≤ 5 394 280 (71.1) 114 (28.9) 1,230 773 (62.8) 457 (37.2)
> 5 to ≤ 10 296 257 (86.8) 39 (13.2) 643 550 (85.5) 93 (14.5)
> 10 to ≤ 15 283 257 (90.8) 26 (9.2) 467 422 (90.4) 45 (9.6)
> 15 to ≤ 20 290 269 (92.8) 21 (7.2) 372 356 (95.7) 16 (4.3)
> 20 to ≤ 25 192 186 (96.9) 6 (3.1) 260 251 (96.5) 9 (3.5)
> 25 to ≤ 37.5 385 371 (96.4) 14 (3.6) 412 403 (97.8) 9 (2.2)
> 37.5 to ≤ 50 203 197 (97.0) 6 (3.0) 212 207 (97.6) 5 (2.4)
> 50 135 128 (94.8) 7 (5.2) 132 131 (99.2) 1 (0.8)
Age
20–29 188 134 (71.3) 54 (28.7)
< 0.0001
2,033 826 (40.6) 1,207 (59.4)
< 0.0001
30–39 572 371 (64.9) 201 (35.1) 2,605 857 (32.9) 1,748 (67.1)
40–49 922 530 (57.5) 392 (42.5) 2,584 852 (33.0) 1,732 (67.0)
50–59 1,302 586 (45.0) 716 (55.0) 2,345 823 (35.1) 1,522 (64.9)
60–69 1,426 541 (37.9) 885 (62.1) 1,609 693 (43.1) 916 (56.9)
≥ 70 1,052 346 (32.9) 706 (67.1) 1,018 534 (52.5) 484 (47.5)
Level of physical activity
Low 3,187 1,337 (42.0) 1,850 (58.0)
< 0.0001
5,995 2,111 (35.2) 3,884 (64.8)
< 0.0001
High 2,275 1,171 (51.5) 1,104 (48.5) 6,199 2,474 (39.9) 3,725 (60.1)
Region
Urban 2,086 982 (47.1) 1,104 (52.9)
0.177
5,148 1,864 (36.2) 3,284 (63.8)
0.007
Rural 3,376 1,526 (45.2) 1,850 (54.8) 7,046 2,721 (38.6) 4,325 (61.4)
High-risk drinking
No 4,667 1,853 (39.7) 2,814 (60.3)
< 0.0001
11,119 3,886 (34.9) 7,233 (65.1)
< 0.0001
Yes 795 655 (82.4) 140 (17.6) 1,075 699 (65.0) 376 (35.0)
Menopause (females only)
No 723 0 (0.0) 723 (100.0)
-
4,831 0 (0.0) 4,831 (100.0)
-Yes: Natural 1,920 0 (0.0) 1,920 (100.0) 2,403 0 (0.0) 2,403 (100.0)
Yes: Artificial 311 0 (0.0) 311 (100.0) 375 0 (0.0) 375 (100.0)
Serum hs-CRP
Low: less than or equal to 3.0 mg/L 4,966 2,262 (45.5) 2,704 (54.5)
0.0846
11,632 4,310 (37.1) 7,322 (62.9)
< 0.0001
High: above 3.0 mg/L 496 246 (49.6) 250 (50.4) 562 275 (48.9) 287 (51.1)
Household income
Low 1,258 412 (32.8) 846 (67.2)
< 0.0001
1,511 601 (39.8) 910 (60.2)
0.2392
Medium–low 1,452 620 (42.7) 832 (57.3) 2,837 1,077 (38.0) 1,760 (62.0)
Medium–high 1,402 690 (49.2) 712 (50.8) 3,742 1,386 (37.0) 2,356 (63.0)
High 1,350 786 (58.2) 564 (41.8) 4,104 1,521 (37.1) 2,583 (62.9)
Occupation
White collar 1,715 994 (58.0) 721 (42.0)
< 0.0001
5,175 1,959 (37.9) 3,216 (62.1)
< 0.0001Sales and services 1,551 890 (57.4) 661 (42.6) 2,521 1,518 (60.2) 1,003 (39.8)
Blue collar 2,196 624 (28.4) 1,572 (71.6) 4,498 1,108 (24.6) 3,390 (75.4)
Educational attainment
≤ Elementary school 1,694 398 (23.5) 1,296 (76.5)
< 0.0001
1,552 531 (34.2) 1,021 (65.8)
0.0065
Middle school 717 293 (40.9) 424 (59.1) 1,086 440 (40.5) 646 (59.5)
High school diploma 1,578 798 (50.6) 780 (49.4) 4,206 1,608 (38.2) 2,598 (61.8)
≥ Bachelor’s degree 1,473 1,019 (69.2) 454 (30.8) 5,350 2,006 (37.5) 3,344 (62.5)
Year
2014 846 272 (32.2) 574 (67.8)
< 0.0001
2,610 759 (29.1) 1,851 (70.9)
< 0.0001
2015 1,260 559 (44.4) 701 (55.6) 3,035 1,251 (41.2) 1,784 (58.8)
2016 1,386 651 (47.0) 735 (53.0) 3,553 1,441 (40.6) 2,112 (59.4)
2017 1,970 1,026 (52.1) 944 (47.9) 2,996 1,134 (37.9) 1,862 (62.1)
Total 5,462 2,508 (45.9) 2,954 (54.1) 12,194 4,585 (37.6) 7,609 (62.4)
Table 1.  General characteristics of study observations by cases of metabolic syndrome and controls (2014–2017).
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Male Female
Odds ratio 95% CI p-value Odds ratio 95% CI p-value
Cigarette type
Non-smoker 1.00 – 1.00 –
Ex-smoker 1.02 (0.75–1.38) 0.903 1.54 (0.98–2.41) 0.062
Current smoker (conventional only) 1.05 (0.75–1.46) 0.790 1.80** (1.02–3.18) 0.042
Current smoker (conventional and electronic) 1.18 (0.76–1.82) 0.464 4.02 (1.48–10.93) 0.006
Smoking history (pack-years)
Non-smoker 1.00 – 1.00 –
≤ 5 0.93 (0.68–1.28) 0.656 0.65 (0.39–1.07) 0.092
> 5 to ≤ 10 0.99 (0.72–1.37) 0.959 0.75 (0.40–1.41) 0.366
> 10 to ≤ 15 1.13 (0.81–1.57) 0.470 0.66 (0.32–1.36) 0.264
> 15 to ≤ 20 1.38 (0.99–1.93) 0.056 1.12 (0.49–2.55) 0.785
> 20 to ≤ 25 1.20 (0.85–1.71) 0.302 0.91 (0.31–2.67) 0.857
> 25 to ≤ 37.5 1.45 (1.04–2.02) 0.028 1.03 (0.39–2.74) 0.948
> 37.5 to ≤ 50 1.53 (1.08–2.18) 0.017 0.90 (0.27–3.05) 0.869
> 50 1.56 (1.07–2.27) 0.020 2.69 (0.32–23.01) 0.366
Age
20–29 1.00 – 1.00 –
30–39 2.62 (2.06–3.32) < 0.0001 2.65 (1.95–3.60) < 0.0001
40–49 3.72 (2.95–4.69) < 0.0001 5.19 (3.87–6.95) < 0.0001
50–59 4.28 (3.40–5.40) < 0.0001 8.06 (5.79–11.21) < 0.0001
60–69 4.99 (3.94–6.33) < 0.0001 12.11 (8.51–17.22) < 0.0001
≥ 70 4.64 (3.60–5.96) < 0.0001 16.67 (11.57–24.04) < 0.0001
Level of physical activity
Low 1.00 – 1.00 –
High 0.88 (0.80–0.98) 0.014 0.85 (0.78–0.94) 0.001
Region
Urban 1.00 – 1.00 –
Rural 1.01 (0.92–1.12) 0.821 1.14 (1.03–1.25) 0.008
High-risk drinking
No 1.00 – 1.00 –
Yes 1.89 (1.67–2.14) < 0.0001 1.52 (1.21–1.91) 0.000
Menopause (females only)
No - 1.00 –
Yes: Natural - 1.13 (0.93–1.37) 0.237
Yes: Artificial - 1.54 (1.23–1.92) 0.000
Serum hs-CRP
Low: less than or equal to 3.0 mg/L 1.00 – 1.00 –
High: above 3.0 mg/L 1.51 (1.26–1.80) < 0.0001 2.45 (2.01–2.98) < 0.0001
Household income
Low 1.00 – 1.00 –
Medium–low 0.94 (0.80–1.10) 0.445 0.94 (0.82–1.08) 0.372
Medium–high 0.87 (0.73–1.02) 0.086 0.83 (0.72–0.96) 0.011
High 0.84 (0.71–1.00) 0.053 0.69 (0.59–0.80) < 0.0001
Occupation
White Collar 1.00 – 1.00 –
Sales and Services 0.89 (0.78–1.01) 0.077 1.01 (0.88–1.16) 0.902
Blue Collar 1.08 (0.93–1.25) 0.336 1.15 (1.03–1.29) 0.015
Educational attainment
≤ Elementary school 1.00 – 1.00 –
Middle school 0.89 (0.74–1.08) 0.240 0.73 (0.62–0.84) < 0.0001
High school diploma 1.00 (0.85–1.18) 0.973 0.57 (0.49–0.66) < 0.0001
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Table 2.  Factors associated with the metabolic syndrome (2014–2017).* *Pseudo R-Square = males: 0.1256, 
females: 0.1133.**Statistically significant values have been printed in bold.
Male Female
Odds ratio 95% CI p-value Odds ratio 95% CI p-value
2014 1.00 – 1.00 –
2015 0.87 (0.74–1.03) 0.106 0.84 (0.73–0.96) 0.012
2016 1.03 (0.90–1.17) 0.688 1.02 (0.90–1.15) 0.805







































High Fasting Plasma Glucose
Metabolic Syndrome
Central Obesity
Figure 1.  Odds of MetS and its components by cigarette usage for males.
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recently been linked to MetS including levels of plasminogen activator inhibitor-1 (PAI-1) should be considered 
in future studies.
Despite these limitations, this investigation shows a statistically significant association between cigarette type 
and MetS, which adheres to the existing body of literature that debates over this relationship. It also implies that 
smoking both conventional cigarettes and electronic cigarettes is more hazardous for MetS and its causal factors, 
relative to not smoking, previously smoking, and /or smoking conventional cigarettes only.
Although South Korea has a relatively low prevalence rate of MetS compared to the rest of the OECD, our 
results suggest that the rate can be lowered even further if individuals are educated of such ideas. Such findings 
also reveal opportunities for intervention with regard to conventional and/or e-cigarette users at risk of meta-
bolic complications.
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